Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Manning

Showing results (381-390 of 821) with videos related to

Pageof 83
Sort By:
Advances in Experimental Medicine and Biology|February 23, 1999
Discovery of novel selective hypotensive vasopressin peptides. A new vasodilating vasopressin receptor?W Y Chan, N C Wo, S Stoev, et al.
The Journal of Clinical Investigation|April 1, 1981
Vascular effects of arginine vasopressin during fluid deprivation in the ratG A Aisenbrey, W A Handelman, P Arnold, et al.
Journal of Medicinal Chemistry|April 1, 1980
[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressinM Kruszynski, B Lammek, M Manning, et al.
The Journal of Biological Chemistry|November 7, 1998
Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cellsM A O'Connell, B L Bennett, F Mercurio, et al.
The Journal of Biological Chemistry|February 10, 1982
Labeling of hemoglobin with pyridoxal phosphateR Benesch, R E Benesch, S Kwong, et al.
Federation Proceedings|June 1, 1982
TransaminasesD E Metzler, J N Jansonius, A Arnone, et al.
BMJ Open|January 24, 2018
Identifying patients at risk of inhospital death or hospice transfer for early goals of care discussions in a US referral center: the HELPS model derived from retrospective dataSantiago Romero-Brufau, Daniel Whitford, Kevin J Whitford, et al.
Molecular Pharmacology|November 1, 1978
Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitorsD Butlen, G Guillon, R M Rajerison, et al.
Experimental Physiology|May 5, 2000
Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassaysW Y Chan, N C Wo, S T Stoev, et al.
International Journal of Impotence Research|June 12, 2002
Long-term results of Essed-Schroeder plication by the use of non-absorbable Goretex sutures for correcting congenital penile curvatureE W Hauck, T Bschleipfer, T Diemer, et al.
Pageof 83

Showing results (381-390 of 821) with videos related to

Sort By:
Pageof 83
Advances in Experimental Medicine and Biology|February 23, 1999
Discovery of novel selective hypotensive vasopressin peptides. A new vasodilating vasopressin receptor?W Y Chan, N C Wo, S Stoev, et al.
The Journal of Clinical Investigation|April 1, 1981
Vascular effects of arginine vasopressin during fluid deprivation in the ratG A Aisenbrey, W A Handelman, P Arnold, et al.
Journal of Medicinal Chemistry|April 1, 1980
[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressinM Kruszynski, B Lammek, M Manning, et al.
The Journal of Biological Chemistry|November 7, 1998
Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cellsM A O'Connell, B L Bennett, F Mercurio, et al.
The Journal of Biological Chemistry|February 10, 1982
Labeling of hemoglobin with pyridoxal phosphateR Benesch, R E Benesch, S Kwong, et al.
Federation Proceedings|June 1, 1982
TransaminasesD E Metzler, J N Jansonius, A Arnone, et al.
BMJ Open|January 24, 2018
Identifying patients at risk of inhospital death or hospice transfer for early goals of care discussions in a US referral center: the HELPS model derived from retrospective dataSantiago Romero-Brufau, Daniel Whitford, Kevin J Whitford, et al.
Molecular Pharmacology|November 1, 1978
Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitorsD Butlen, G Guillon, R M Rajerison, et al.
Experimental Physiology|May 5, 2000
Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassaysW Y Chan, N C Wo, S T Stoev, et al.
International Journal of Impotence Research|June 12, 2002
Long-term results of Essed-Schroeder plication by the use of non-absorbable Goretex sutures for correcting congenital penile curvatureE W Hauck, T Bschleipfer, T Diemer, et al.
Pageof 83